Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Benjamin Mitchell

Physician Assistant Florence, SC Physician Assistant

NPI 1487121612 CMS profile 10682409

101 S Ravenel St Ste 270, Florence, SC 29506

Open in the dashboard

General payments

$1,657

41 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Mitchell of Florence, SC is reported in the CMS Open Payments database as having received $1,657 across 41 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $424 15
2024 General $284 6
2023 General $72 5
2022 General $686 11
2021 General $191 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Mitchell
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Benjamin Mitchell were reported at $424. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Benjamin Mitchell Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $191 $132 $37–$438 $132
2022 $686 $155 $48–$522 $149
2023 $72 $167 $52–$557 $160
2024 $284 $178 $55–$600 $164
2025 $424 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Maquet Cardiovascular U.S. Sales, L.L.C. $817 7 payments
  2. Atricure, Inc. $228 11 payments
  3. Stryker Corporation $208 5 payments
  4. Abiomed $125 3 payments
  5. Davol Inc. $73 3 payments
  6. Baxter Healthcare $41 3 payments
  7. Cordis US Corp. $33 2 payments
  8. Peerless Surgical Inc. $28 1 payment
  9. AstraZeneca Pharmaceuticals LP $28 2 payments
  10. Boston Scientific Corporation $24 1 payment
  11. Other $53 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,263 39 payments
  2. Travel and Lodging $394 2 payments
Products named General payments · program years 2021–2025
  1. Vasoview Hemopro 2 $725 6 payments
  2. ARTIX MT $124 3 payments
  3. SYNERGY ABLATION SYSTEM $123 6 payments
  4. ATRICLIP LAA EXCLUSION SYSTEM $94 5 payments
  5. Acrobat-I Stabilizer $91 1 payment
  6. Impella $68 1 payment
  7. FLOWTRIEVER CATHETER, S $63 2 payments
  8. CT THROMBECTOMY SYSTEM KIT $63 2 payments
  9. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $60 3 payments
  10. Progel Applicator Spray Tips $45 2 payments
  11. Other $237 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

298

Median for Physician Assistant: 241

Drug cost

$1,344

Median for Physician Assistant: $4,110

Branded share of claims

19.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 39 $319
Atorvastatin Calcium Generic 35 $292
Amiodarone Hcl Generic 17 $165
Clopidogrel Clopidogrel Bisulfate Brand 44 $162
Chlorhexidine Gluconate Generic 41 $159
Potassium Chloride Generic 28 $67
Metoprolol Tartrate Generic 30 $66
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $42
Oxycodone Hcl Generic 17 $40
Furosemide Generic 34 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$6,930

Medicare's payments for the services billed

Medicare patients

54

Average age 72

Services billed

83

23 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 70%
Diabetes 59%
Heart failure 52%
COPD 50%
Arthritis 50%
Chronic kidney disease 39%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

41 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record